Search Share Prices
AZN Headlines - AstraZeneca sells rights to two of its ‘non-core’ drugs for almost US$1bn
AstraZeneca PLC (LON:AZN) has sold off the rights to two of its drugs for almost US$1bn to Grünenthal – the German pharma giant which first developed and sold thalidomide. FTSE 100-listed Astra is sel...
AstraZeneca share price dips as analysts flag ‘messy’ results
Shares in AstraZeneca (LON:AZN) have fallen deep into the red in today’s session as analysts at BMO Capital Markets trimmed their earnings forecasts for the blue-chip drugmaker. The move comes ...
AstraZeneca share price: Group strengthens partnership with Innate Pharma
AstraZeneca (LON:AZN) has moved to strengthen its position in the immuno-oncology field, expanding its collaboration with French biotech company Innate Pharma, the Anglo-Swedish group has said.
AstraZeneca reveals trial of Lynparza drug reduces risk of ovarian cancer worsening
AstraZeneca PLC (LON:AZN) said a phase III trial of its Lynparza drug greatly showed to greatly reduce the risk of ovarian cancer worsening. Lynparza halted or reversed tumour growth in 60% of patient...